Crispr Therapeutics is an emerging gene editing company focused on the development of Crispr/Cas9-based therapeutics. The company's proprietary platform specializes in clustered regularly interspaced ...

New research from Mandiant has claimed financially motivated actors are the new norm, with over half (55%) of threat groups ...

Learn more about whether Procore Technologies, Inc. or Qualys, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

Just in time for the arrival of warmer weather, the Nebraska Department of Health and Human Services has launched a new tick ...

During the first quarter of 2025, operating revenue mostly comprised Research Tax Credit of 2.3 million compared to €1.6 million for the same period in 2024. This increase reflects the progress of the ...

Q1 2025 Earnings Conference Call April 24, 2025 8:15 AM ETCompany ParticipantsRavi Pamnani - Senior Vice President of ...

There's just no getting ... cash and physical cards, they said. Over on X, another customer has suggested that if stores are still not accepting contactless, they should place signs at the door ...